CareDx stockholders elect three Class I directors and approve 2024 Equity Incentive Plan

CareDx, Inc.

George W. Bickerstaff III, Christine M. Cournoyer, and Hannah Valantine, M.D. elected as Class I directors, terms expiring 2027.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2024, with 47.1M votes for.
Advisory approval of named executive officer compensation: 38.9M for, 1.6M against.
2024 Equity Incentive Plan approved (23.4M for, 16.6M against); authorizes up to 3.5M shares for equity awards.
Approximately 91% of outstanding shares (47.4M of 52.0M) represented at meeting, establishing strong quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.